Clinical Finance Services - Clinical Finance Consulting

From initial planning through study execution and winddown, every variable has a downstream impact on a company’s financials.

Overall study costs exceeding initial budgets
- Changes to timelines and study design have a ripple effect that can result in many unforseen increased costs
- Enrollment Mix (US vs Ex-US)
Expense timing impacting short term fiscal budgets
- Shifts in variable spend attributed to patient activities
- Lack of transparency in third party contracts and expense incurred
- CRO change order historical expense recoupment
Substantial and inconsistent cash outflows
- CRO / Third party milestone contracts
- Investigator grant payments

Initial Budget and Ongoing Trial Expense Forecasting
- Establishing milestone and performance financial incentives and penalties that hold CRO and other Third-parties accountable for performance
- Change order support to determine underutilized services as studies progress allowing for capital to be reallocated

Improving forecast accuracy and avoiding unexpected adjustments
- Patient level forecast specific to each site budget and study design
- Third-party trended expense analysis and evaluation of contractual obligations

Increasing transparency and accuracy of cash outflows
- 13-week cash forecast to determine short-term capital requirements
- Complete study forecast cash outflows to support company long range plan and annual budgeting exercises